Celanese CORP Form 4 insider transactions
NYSE
Celanese Corp Director Ganesh Moorthy acquired 1,000 shares of common stock, signaling confidence in the company.
NYSE
A Celanese Corp director acquired 2,400 shares of common stock on August 14, 2025, increasing their beneficial ownership.
NYSE
Celanese Corporation's Director, Kim K.W. Rucker, acquired 6.01 shares of phantom stock as dividend equivalents under a deferred compensation plan.
NYSE
Celanese Director Deborah J. Kissire acquired 3.74 shares of phantom stock as dividend equivalents, increasing her total beneficial ownership to 5,916.748 shares.
NYSE
Celanese Corporation director Jay V. Ihlenfeld acquired 6.47 phantom stock units as dividend equivalents on deferred compensation.
NYSE
Celanese Corporation director Kathryn Hill acquired 1.86 shares of phantom stock as dividend equivalents, increasing her beneficial ownership to 2,946.61 shares.
NYSE
Celanese Corporation Director Timothy Go acquired 0.71 shares of phantom stock as dividend equivalents under a deferred compensation plan.
NYSE
Celanese Corporation director Edward G. Galante acquired 4.3 shares of phantom stock as dividend equivalents, increasing his total beneficial ownership to 6,797.555 shares.
NYSE
Celanese Corp's Senior Vice President of Acetyls, Mark Christopher Murray, reported the disposition of 485 common shares at $60.85 each, withheld for tax purposes upon the vesting of restricted stock units.
NYSE
Celanese Corporation's Senior Vice President of Acetyls, Mark Christopher Murray, acquired 1,479 shares of common stock at $52.18 per share, increasing his direct beneficial ownership.
NYSE
Director Michael Koenig of Celanese Corporation reports the disposal of 335 shares of common stock to cover tax obligations arising from vested restricted stock units.
NYSE
Director Kim K.W. Rucker reports the disposition of 1,114 common stock shares and acquisition of 1,114 phantom stock shares due to deferred compensation plan.
NYSE
Director Deborah J. Kissire reports the disposition of 1,114 shares of Celanese Corp common stock in exchange for an equal number of phantom stock units.
NYSE
Form 4: Celanese Corp Director Timothy Go Reports Transaction Involving Common Stock and Phantom Stock
Director Timothy Go reports disposition of 1,114 shares of Celanese Corp common stock in exchange for an equal number of phantom stock shares on May 15, 2025, following the vesting of restricted stock units.
NYSE
Director Bruce E. Chinn reports acquiring 3,376 shares of Celanese Corp common stock through a restricted stock unit grant and disposing of 4,286 shares.
NYSE
Form 4: Celanese Director Scott McDougald Sutton Reports Acquisition of 3,376 Shares of Common Stock
Director Scott McDougald Sutton reports acquiring 3,376 shares of Celanese Corp common stock through a restricted stock unit grant.
NYSE
Director Kim K.W. Rucker reports acquisition of restricted stock units and phantom stock, along with disposal of common stock.
NYSE
Director Ganesh Moorthy reports acquisition of 3,376 shares of Celanese Corp stock via a restricted stock unit grant and disposal of 3,000 shares held in a trust.
NYSE
Christopher J. Kuehn, a director at Celanese Corp, received an annual grant of 3,376 restricted stock units on May 9, 2025, which vest in full on the one-year anniversary of the grant date.
NYSE
Director Michael Koenig reports acquiring and disposing of Celanese Corp common stock related to a restricted stock unit grant.
NYSE
Director Deborah J. Kissire reports acquisition of restricted stock units and phantom stock, along with holdings of common stock.
NYSE
Director Jay V. Ihlenfeld reports acquisition of restricted stock units and phantom stock in Celanese Corp.
NYSE
Director David F. Hoffmeister acquired 3,376 shares of Celanese Corp stock through a restricted stock unit grant, according to a recent SEC filing.
NYSE
Director Edward G. Galante reports acquisition and disposal of Celanese Corp stock and phantom stock.
NYSE
Director Timothy Go reports acquisition of 3,376 restricted stock units of Celanese Corp, vesting in one year, with subsequent deferral into phantom stock.
NYSE
Kathryn Hill, a director of Celanese Corp, reported transactions involving common stock and phantom stock, including acquisitions and disposals, according to a Form 4 filing with the SEC.
NYSE
Director Ganesh Moorthy reports purchasing 1,000 shares of Celanese Corp common stock at $53.2896 per share, increasing his total holdings.
NYSE
Director Kathryn Hill reports acquisition of phantom stock representing dividend equivalents on deferred compensation.
NYSE
Director Kim K.W. Rucker reports an acquisition of phantom stock representing dividend equivalents on deferred compensation.
NYSE
Director Deborah J. Kissire reports acquisition of phantom stock representing dividend equivalents on deferred compensation.